SolaranRx (STC)
Funding Details
- Awarder
- Inbox
- Date Award
- May 04, 2015
- Vertical
- Precision Medicine
- Funding URL
- View Funding Page
- Funding Amount:
- $100,000
Company Info
- Company Description
- SolaranRx, Inc. is developing a new class of precision medicine: therapies and companion imaging agents for the treatment of metastatic melanoma. This merger between therapeutics and diagnostics, often referred to as theranostics, constitutes a new level of precision medicine for treating metastatic melanoma.
- Market
- Metastatic Melanoma Treatment
- Location
- Albuquerque, New Mexico, USA